IR-News

AUSSENDER



Medigene AG
Ansprechpartner: Medigene PR/IR
Tel.: +49 89 2000 33 3301
E-Mail: investor@medigene.com

FRüHERE MELDUNGEN

08.06.2018 - 19:35 | Medigene AG
08.06.2018 - 19:35 | Medigene AG
06.06.2018 - 19:54 | Medigene AG
06.06.2018 - 19:54 | Medigene AG
04.06.2018 - 20:15 | Medigene AG
pta20180608037
Release according to article 40 para. 1 WpHG

Medigene AG: Release according to Article 40, Section 1 of the WpHG

Voting Rights Announcement

Planegg (pta037/08.06.2018/19:40) - Release of Voting Rights Announcement

Notification of Major Holdings

1. Details of issuer:
Medigene AG, Lochhamer Straße 11, 82152 Planegg, Germany

2. Reason for notification:
Acquisition / disposal of shares with voting rights

3. Details of person subject to the notification obligation
Name: QVT Associates GP LLC
City and country of registered office: Dover, Delaware, USA - United States

4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3
QVT Family Office Fund LP

5. Date on which threshold was crossed or reached
25.05.2018

6. Total positions

% of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer
Resulting situation 4.81 0.00 4.81 22,313,732
Previous notification 9,84 0,0 9,84

7. Notified details of the resulting situation

a. Voting rights attached to shares (Sec.s 33, 34 WpHG)

ISIN absolute direct (Sec. 33 WpHG) absolute indirect (Sec. 34 WpHG) in % direct (Sec. 33 WpHG) in % indirect (Sec. 34 WpHG)
DEOOOA1X3WOO 0 1,072,879 0.00 4.81
Total: 1,072,879 4.81

b.1. Instruments according to Sec. 38 para. 1 No. 1 WpHG

Type of instrument Maturity / Expiration Exercise or conversion period Voting Rights Absolute Voting Rights in %
Total:

b.2 Instruments according to Sec. 38 para. 1 No. 2 WpHG

Type of instrument Maturity / Expiration Exercise or conversion period Cash or physical transaction Voting Rights Absolute Voting Rights in %
Total:

8. Information in relation to the person subject to the notification obligation

Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity

Name % of voting rights if 3% or higher % of voting rights through instruments if 5% or higher Total of both if 5% or higher
QVT Associates GP LLC
QVT Family Office Onshore LP
QVT Family Office Fund LP 3.36
QVT Fund IV LP

9. In case of proxy voting according to § 34 para. 3 WpHG

Date of general meeting: N/A

10. Other useful information
Please be advised that the voting rights which are held by QVT Family Office Fund LP (formerly known as QVT Fund V LP) are not attributed to QVT Offshore Ltd. anymore (see previous notification of QVT Offshore Ltd. published on 18 December 2017). (end)

emitter: Medigene AG
Lochhamer Straße 11
82152 Planegg
Germany
contact person: Medigene PR/IR
phone: +49 89 2000 33 3301
e-mail: investor@medigene.com
website: www.medigene.de
stock exchanges: regulated market in Frankfurt; free market in Dusseldorf, free market in Hamburg, free market in Hannover, free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate
ISIN(s): DE000A1X3W00
|
|
98.207 Abonnenten
|
166.154 Meldungen
|
65.395 Pressefotos

BUSINESS

21.09.2018 - 11:30 | Travel Industry Club Austria
21.09.2018 - 09:30 | OPWZ - Österr. Produktivitäts- und Wirtschaftlichkeits-Zentrum
21.09.2018 - 09:15 | Möbel Polt GmbH & Co KG
21.09.2018 - 06:15 | pressetext.redaktion
20.09.2018 - 17:20 | Pädagogische Hochschule Niederösterreich
Top